Literature DB >> 12874747

Hyperphosphatemia in dialysis patients: is there a role for focused counseling?

Rajiv D Poduval1, Christine Wolgemuth, Janice Ferrell, Mary S Hammes.   

Abstract

BACKGROUND: Elevated serum phosphorus (P) and calcium-P product (CaXP) are associated with cardiac mortality in dialysis patients. A CaXP <55 is considered acceptable by most authorities. Because nutrition practices can modulate CaXP, we designed a survey to study the impact of the patients' levels of education and disease awareness on their CaXP.
METHODS: A survey questionnaire with 5 didactic questions pertaining to hyperphosphatemia and P-binders and 5 questions related to patient attitudes and beliefs was administered to all patients in a hemodialysis unit. The association of CaXP >55 with the patients' level of education, their score on the survey (didactic part, score 0 to 5), parathyroid hormone (PTH) levels, hyperkalemia, hypertension, and vascular disease were studied.
RESULTS: Of the 117 patients (61 men, age 56.5 +/- 18 years) who participated in the survey, 49 (42%) had CaXP >55 and 100 (85%) were on P binders. Thirty-seven (31.6%) had at least some college education. Eighty-seven patients (74%) failed to identify foods rich in P; 61% were unaware of complications related to high CaXP. Patients with CaXP >55 were less likely to have college education (20% versus 39%, P =.04), and had lower survey scores (2.4 +/- 1.3 versus 2.6 +/- 1.4, P = NS). Patients with college education scored higher (2.9 +/- 1.1 versus 2.3 +/- 1.4, P =.014). Furthermore, CaXP >55 was significantly associated with hyperkalemia (P =.02), high PTH levels (P <.001), and hypertension (P =.02), but not with >Kt/V, URR, type of hemodialysis access, or vascular diseases.
CONCLUSION: The majority of patients in the survey were ignorant of basic facts pertaining to high P and CaXP. The association of CaXP >55 with hyperkalemia, and not with Kt/V, suggests dietary noncompliance rather than inadequate dialysis. Patients with less education were more likely to have CaXP >55. Because this related mostly to misperception of simple facts that affect dietary habits, there is need for focused counseling of these patients at a level appropriate for their literacy skills.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874747     DOI: 10.1016/s1051-2276(03)00070-0

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  8 in total

1.  Assessment of oral health status and inflammatory markers in end stage chronic kidney disease patients: A cross-sectional study.

Authors:  Lokesh Sharma; Devina Pradhan; Rahul Srivastava; Manas Shukla; Omveer Singh
Journal:  J Family Med Prim Care       Date:  2020-05-31

2.  Phosphate Removal by Peritoneal Dialysis: The Effect of Transporter Status and Peritoneal Dialysis Prescription.

Authors:  Cecile Courivaud; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

3.  Managing serum phosphate in haemodialysis patients: time for an innovative approach?

Authors:  A Collinson; M McMullan; W Y Tse; H Sadler
Journal:  Eur J Clin Nutr       Date:  2014-01-15       Impact factor: 4.016

4.  Dietary phosphorus acutely impairs endothelial function.

Authors:  Emi Shuto; Yutaka Taketani; Rieko Tanaka; Nagakatsu Harada; Masashi Isshiki; Minako Sato; Kunitaka Nashiki; Kikuko Amo; Hironori Yamamoto; Yukihito Higashi; Yutaka Nakaya; Eiji Takeda
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

Review 5.  Management of natural and added dietary phosphorus burden in kidney disease.

Authors:  Adamasco Cupisti; Kamyar Kalantar-Zadeh
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

6.  Fluctuating plasma phosphorus level by changes in dietary phosphorus intake induces endothelial dysfunction.

Authors:  Eriko Watari; Yutaka Taketani; Tomoyo Kitamura; Terumi Tanaka; Hirokazu Ohminami; Maerjianghan Abuduli; Nagakatsu Harada; Hisami Yamanaka-Okumura; Hironori Yamamoto; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2014-12-16       Impact factor: 3.114

Review 7.  An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease.

Authors:  Kelly Lambert; Judy Mullan; Kylie Mansfield
Journal:  BMC Nephrol       Date:  2017-10-23       Impact factor: 2.388

Review 8.  Phosphate-control adherence in hemodialysis patients: current perspectives.

Authors:  Ebele M Umeukeje; Amanda S Mixon; Kerri L Cavanaugh
Journal:  Patient Prefer Adherence       Date:  2018-07-04       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.